SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Palladyne AI announced preliminary Q2 2026 financial results, including revenue of approximately $5.8 million (up 480% year-over-year and 66% sequentially), backlog of $24.0 million, and cash position of $44.0 million. The announcement includes management commentary and forward-looking statements typical of quarterly earnings releases.
View raw filing on EDGAR →The filing discloses the appointment of Jeremy Bender, Ph.D., M.B.A., as a Class II director to Aura Biosciences' Board, effective July 7, 2026. The Board unanimously appointed Dr. Bender to fill a newly created vacancy and assigned him to the Compensation Committee and Nominating and Corporate Governance Committee. This is a clear executive appointment event under Item 5.02, with material significance given Dr. Bender's substantial biotechnology leadership experience and the company's advancement toward regulatory approval of its lead candidate bel-sar.
View raw filing on EDGAR →Seres Therapeutics announced top-line clinical results from an investigator-sponsored trial of SER-155 in immune checkpoint inhibitor-related enterocolitis (irEC), with 80% of participants achieving the primary endpoint of immunosuppressive-free clinical response at Day 15 and no drug-related serious adverse events. This material clinical development milestone was disclosed via press release and updated corporate presentation on July 8, 2026.
View raw filing on EDGAR →The filing discloses a press release providing Bitcoin production and mining operational metrics for the month ended June 30, 2026, including Bitcoin mined (8.7 BTC), sold (13.1 BTC), treasury holdings (318.3 BTC valued at $18.6 million), and energy-sales revenue ($30,000 for June, ~$117,000 forecast for Q2). While styled as an "operational update" rather than traditional earnings, this constitutes a periodic financial and operational results disclosure material to investors in a Bitcoin mining company, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →Energy Transfer LP entered into an underwriting agreement on July 6, 2026, to issue $1.75 billion in aggregate principal amount of junior subordinated notes due 2057 (Series 2026A and Series 2026B), with settlement expected July 20, 2026. Proceeds will be used to redeem preferred units, refinance existing indebtedness, and repay commercial paper and revolving credit facility borrowings.
View raw filing on EDGAR →Goldman Sachs Real Estate Finance Trust Inc completed an unregistered private offering of Class I and Class S common stock, raising approximately $30.8 million in aggregate consideration from accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →The company declared and will pay monthly distributions to stockholders across six classes of common stock (Class S, I, NV-1, NV-2, F-I, F-II) on or about July 10, 2026, with per-share amounts ranging from $0.1486 to $0.2250.
View raw filing on EDGAR →Stockholders approved five proposals at the Annual Meeting held on July 8, 2026: election of three Class II directors (Stephen A. Berenson, Claire M. Fraser, and Richard N. Kender), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, approval of an amendment to the 2025 Incentive Award Plan increasing available shares by 900,000, and approval of an adjournment provision. All proposals passed.
View raw filing on EDGAR →The filing discloses termination of two material definitive agreements: (1) the GSK Collaboration and License Agreement for development of investigational monoclonal antibodies latozinemab and nivisnebart, effective January 2, 2027, following failed Phase 3 and Phase 2 clinical trials; and (2) the Loan and Security Agreement with Hercules Capital, which the Company repaid in full ($10.4M principal plus interest and charges) on July 8, 2026. The GSK termination represents a material change in the Company's pipeline and strategic partnership following clinical trial failures, while the loan repayment signals a significant capital event. While Item 1.02 covers termination of material agreements, the substance here—loss of a major collaboration and debt restructuring—most closely aligns with material M&A/strategic activity, though `financial_other` (debt repayment) or `operational_other` (partnership termination) could also apply.
View raw filing on EDGAR →The filing discloses the Board's recommendation regarding a revised unsolicited tender offer from Zodiac Partners II to acquire all outstanding shares at $0.84 per share. This is a material acquisition activity (change of control attempt) that directly affects shareholders' rights and the company's future. The Board's formal rejection and recommendation that stockholders not tender their shares is a significant corporate event requiring disclosure under Item 7.01 and Schedule 14D-9 filing obligations.
View raw filing on EDGAR →Phoenix Energy One entered into an indenture on July 7, 2026, providing for the issuance of up to $100 million in Senior Subordinated Junior Lien Notes. This is a creation of a new direct financial obligation—a debt issuance registered on Form S-1 with a 10-year maturity and interest rates of 6.00% to 7.00% per annum. The disclosure of the indenture terms, collateral arrangements, and intercreditor agreement clearly indicates a material debt financing event.
View raw filing on EDGAR →The filing discloses entry into a "Second Amending Agreement" that amends an existing credit agreement, extending maturity dates for the 5 Year Facility (from June 25, 2030 to June 25, 2031) and the 2 Year Facility (from June 25, 2027 to June 25, 2028). While this is technically an amendment to existing debt rather than issuance of new debt, it represents a material modification of direct financial obligations that affects the company's debt structure and refinancing timeline. The extension of maturity dates is a significant financial event material to investors assessing the company's capital structure and liquidity profile.
View raw filing on EDGAR →The disclosure centers on an amended and restated employment agreement with CEO Adam Metz that modifies his compensatory arrangements, specifically increasing his target annual bonus from $1,225,000 to $1,300,000 and establishing new bonus measurement terms tied to a six-month performance period. While the agreement also addresses his continued service as CEO, the substantive changes disclosed are compensation-focused, making this an exec_compensation event rather than an appointment.
View raw filing on EDGAR →Contango Silver & Gold amended its credit facility (Amendment No. 13) to convert 15,000 ounces of hedged gold contracts into approximately $33.0 million of new debt, plus $715,000 for put option contracts, increasing total principal from $12.6 million to $46.3 million with a reduced interest rate of 7.40% and scheduled repayments through June 2027.
View raw filing on EDGAR →Invitation Homes closed an underwritten public offering of $500 million aggregate principal amount of 4.950% Senior Notes due 2032 on July 8, 2026, creating a direct financial obligation through the issuance of senior unsecured notes with specified terms, interest rate, maturity date, and redemption provisions.
View raw filing on EDGAR →Nuveen announced the successful completion of NREX I, a $58.7 million Delaware Statutory Trust offering sponsored by a subsidiary of Nuveen Global Cities REIT. This is a material capital-raising and product-launch event for the registrant's real estate investment business, but it does not fit neatly into the specific financial categories (debt_issuance, dilutive_issuance, dividend_distribution) because it is a DST offering structured as a tax-advantaged exchange vehicle rather than a direct debt or equity issuance by the registrant itself. The event is clearly operational and strategic in nature—announcing a successful product closure and capital deployment—making operational_other the most appropriate classification.
View raw filing on EDGAR →NOVONIX announced ASX approval of a Share Purchase Plan (SPP) permitting issuance of new shares to eligible shareholders at $0.16 per share, representing a 31.2% discount to the 5-day VWAP. The announcement discloses the mechanics of an equity issuance at a material discount without shareholder approval (via ASX waivers), with expected dilution of approximately 2.17% and a cap of 30% of outstanding shares. This is a dilutive equity issuance comparable to a private placement or PIPE structure.
View raw filing on EDGAR →Fortress Credit Realty Income Trust completed an unregistered sale of 644,560 common shares across multiple share classes for approximately $12.9 million in gross proceeds, conducted pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions.
View raw filing on EDGAR →The company declared distributions to shareholders across ten classes of common shares, with net distributions ranging from $0.1087 to $0.1542 per share, payable on or about July 1, 2026.
View raw filing on EDGAR →Fortress Net Lease REIT issued 6.8 million common shares for approximately $71.9 million in gross proceeds on July 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions from registration.
View raw filing on EDGAR →The company declared distributions to shareholders across six classes of common shares, with per-share amounts ranging from $0.0550 to $0.0734 (gross), payable on or about July 1, 2026.
View raw filing on EDGAR →Vistance Networks completed the sale of its RUCKUS reporting segment to Belden, Inc. for $1.846 billion in cash on July 1, 2026. This is a material disposition of assets representing a strategic shift that meets the criteria for discontinued operations under ASC 205-20. The transaction is disclosed under Item 2.01 (Completion of Acquisition or Disposition of Assets) and involves a significant portion of the company's business, making it a core M&A activity event.
View raw filing on EDGAR →Jane Pocock, currently CEO of Copart UK, has been appointed to the position of President of Copart, effective August 1, 2026, filling a previously vacant position. The company emphasized her track record leading the UK and Ireland business and her promotion to a global leadership position.
View raw filing on EDGAR →Catalyst Pharmaceuticals stockholders approved the anticipated merger with Angelini Pharma at a special meeting held on July 8, 2026, with the Merger Proposal receiving approximately 98.8% of votes cast (97,340,180 votes in favor). Directors' conditional resignations were disclosed in connection with the anticipated consummation of the Merger Agreement dated May 6, 2026, which constitutes a material acquisition and change of control event.
View raw filing on EDGAR →The 6-K discloses results of an extraordinary general meeting held on July 8, 2026, at which shareholders approved multiple material corporate actions: share redesignation, increase of authorized share capital from US$50,000 to US$1,200,000 (a 24-fold increase), a 240-to-1 share consolidation, amended articles of association, and a share subscription agreement. These approvals would materially affect the registrant's capital structure and future financing capacity.
View raw filing on EDGAR →Telesat announced an agreement in principle with Canada's Defence Investment Agency to provide Mil-Ka-band satellite connectivity services for the ESCP-P Arctic military communications program. This is a material operational and strategic contract win with a government customer that will leverage Telesat Lightspeed services, though the agreement is subject to execution of a definitive contract. The disclosure emphasizes expected financial impact to be shared after contract execution, making it a significant business development event rather than a routine announcement.
View raw filing on EDGAR →The press release announces a 1-for-10 reverse stock split undertaken "with the objective of meeting the minimum $1.00 per Ordinary Share bid requirement for maintaining the listing of the Ordinary Shares on The Nasdaq Capital Market." This disclosure directly addresses delisting risk — the company is taking corrective action to avoid falling below Nasdaq's continued listing standards. The explicit reference to the minimum bid price requirement and the stated purpose of maintaining listing status are hallmarks of delisting-risk disclosure.
View raw filing on EDGAR →The report discloses that trading in the Company's Class A ordinary shares has been suspended since October 6, 2025, and remains suspended. The Company is furnishing this report to address concerns bearing upon continued listing on The Nasdaq Capital Market. The report outlines multiple remedial measures (re-domiciliation, abolition of dual-class structure, board restructuring, and undertakings regarding foreign private issuer exemptions) intended to restore trading and address delisting risk. This is a material disclosure of delisting risk and suspension of trading, which directly threatens the registrant's continued listing status.
View raw filing on EDGAR →The filing discloses a material modification to a previously announced business combination between CEPO and BSTR Holdings, Inc. The parties have agreed that they "will not complete the proposed business combination on the terms initially set forth in the business combination agreement, dated July 16, 2025" and are "discussing a potential revised structure and amended terms." The extraordinary general meeting scheduled for July 10, 2026 has been indefinitely postponed, and the pending private placements will not be required to close. This constitutes a material change to the M&A transaction structure and timeline that would significantly affect investor expectations.
View raw filing on EDGAR →MSP Recovery disclosed that its Class A common stock and publicly traded warrants will be transferred from the OTC Pink Limited Information market tier to the OTC Markets Group's "Expert Market" effective July 17, 2026, due to failure to file delayed annual and quarterly reports (Form 10-K for 2025 and Form 10-Q for Q1 2026). This transfer materially restricts trading availability and liquidity, as Expert Market quotations are limited to unsolicited quotes for sophisticated investors only, representing a significant delisting risk and loss of public market access.
View raw filing on EDGAR →The Board of Directors appointed Darcy Bajko to the position of Chief Commercial Officer effective July 31, 2026, with an annual salary of $315,000, bonus eligibility up to 30%, and a stock option grant of 150,000 shares.
View raw filing on EDGAR →The Company received a Nasdaq minimum bid price deficiency notice on January 22, 2026, triggering a 180-day compliance period ending July 21, 2026. The July 7, 2026 Compliance Letter confirms the Company has regained compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days (June 22–July 6, 2026), resolving the delisting risk. This disclosure directly addresses a continued listing rule failure and its resolution, which is material to investors assessing the registrant's exchange status.
View raw filing on EDGAR →This Item 8.01 disclosure centers on the completion of a SPAC's IPO, over-allotment option exercise, and private placement activities, culminating in $233.1M in trust account proceeds. However, the auditor's report contains an explicit "Substantial Doubt about the Company's Ability to Continue as a Going Concern" statement, noting the Company "has limited cash and will continue to incur significant costs in pursuit of an acquisition." This going-concern language is the most material and legally significant element of the filing, yet the Item 8.01 prose itself focuses on transaction mechanics rather than the going-concern risk. The domain is unclear: the primary narrative is financial/operational (IPO completion), but the most material disclosure is existential (going-concern doubt). This ambiguity between domains warrants `other_material` rather than forcing a fit into `going_concern` (which typically appears as the primary Item focus) or `financial_other` (which would understate the existential risk).
View raw filing on EDGAR →Nuvini announced the full repayment of a R$61 million non-convertible debenture facility at scheduled maturity. While this is a debt retirement (not a new debt issuance), it is a material financial event affecting the company's capital structure, covenant obligations, and asset liens. The press release emphasizes the deleveraging trajectory and release of financial covenants and asset liens, which would affect a reasonable investor's assessment of financial flexibility and balance-sheet strength. This does not fit the specific `debt_issuance` type (which covers creation of new obligations) but is clearly a material financial event warranting disclosure.
View raw filing on EDGAR →Cheer Holding held its 2026 Annual General Meeting on July 7, 2026, with shareholders approving four material proposals: re-election of directors Jia Lu and Zhihong Tan, ratification of Enrome LLP as auditor, approval of a significant increase in authorized Class A share capital from 3.3 million to 50 million shares, and adoption of the 2026 Equity Incentive Plan.
View raw filing on EDGAR →The disclosure centers on special equity awards (500,000 RSUs, 100,000 RSUs, and 400,000 stock options) granted to the Executive Chairman on July 6, 2026, approved by the Compensation Committee. This is a compensatory arrangement for a named executive officer, not a departure or appointment, making exec_compensation the appropriate classification under Item 5.02(e).
View raw filing on EDGAR →Banco de Chile announced the placement of senior, dematerialized bearer bonds (Serie FG Bonds) in the local Chilean market on July 8, 2026, for a total amount of CLF 250,000 with maturity November 1, 2030, at an average placement rate of 2.74%. This is a creation of a new direct financial obligation and was filed as Material Information with the Chilean Financial Market Commission, meeting the definition of debt_issuance.
View raw filing on EDGAR →Borealis Foods received a notice from Nasdaq on July 2, 2026, indicating failure to satisfy the minimum Market Value of Listed Securities (MVLS) requirement of $35,000,000 under Nasdaq Listing Rule 5550(b)(2), with no current compliance with alternative standards. The company has a 180-day compliance period (until December 29, 2026) to regain compliance, and faces potential delisting if it fails to do so. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →AIB Data Centers released an investor presentation disclosing its business strategy, operational footprint, power-first data center development model, 570 MW pipeline across six active sites, management team credentials, and financial outlook. The presentation provides material updates on the company's growth trajectory, power acquisition strategy, and revenue projections.
View raw filing on EDGAR →This is a press release announcing preliminary H1 2026 financial results for SEALSQ Corp, a subsidiary of WiseKey International Holding. The disclosure reports H1 2026 revenue of approximately $11 million (120% year-over-year growth), reaffirms FY 2026 guidance of 50%–100% revenue growth, and provides detailed financial highlights including cash position ($495 million) and business pipeline ($225 million through 2029). The document explicitly states "SEALSQ Corp Reports Preliminary H1 2026 Results" and contains unaudited financial figures for the six-month period ended June 30, 2026, making it a classic earnings release announcement.
View raw filing on EDGAR →This is a press release announcing preliminary H1 2026 financial results for SEALSQ Corp, disclosing revenue of approximately $11 million (120% year-over-year growth) and reaffirming FY 2026 guidance of 50%–100% revenue growth. The document explicitly states "SEALSQ Corp Reports Preliminary H1 2026 Results" and provides detailed financial highlights including revenue figures, cash position, and business pipeline. This is a classic earnings release announcing interim financial results, which is material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →This press release announces a 10-for-1 share consolidation effective July 13, 2026, affecting all outstanding Class A, B, and C ordinary shares. While a share consolidation is a capital structure modification rather than a discrete governance event like an election or appointment, it is a material corporate action that affects share count, trading mechanics (new CUSIP), and shareholder holdings. The disclosure is governance-related (affecting the company's capitalization structure) but does not fit the specific named governance categories; thus `governance_other` is appropriate. The materiality is clear: reasonable investors would consider this information important to their assessment of the company's capital structure and trading position.
View raw filing on EDGAR →The 6-K discloses preliminary unaudited financial results for the six-month period ended June 30, 2026 (H1 2026), including revenue of approximately $11 million (120% year-over-year growth) and cash position of $495 million. This is a results announcement, not a periodic financial report itself, and would materially affect a reasonable investor's assessment of the registrant's operational performance and financial condition.
View raw filing on EDGAR →Ohmyhome Ltd's 2026 Annual General Meeting will consider authorization to increase authorized share capital from US$7.5 billion to US$1 trillion, a capital reduction reducing par value from US$0.01 to US$0.0000001 per share, and a broad share subdivision/consolidation authority with a ratio range of 2:1 to 5,000:1 over two years. The meeting will also address re-appointment of four directors and ratification of the auditor.
View raw filing on EDGAR →Presidio Production Company completed the acquisition of Canyon Creek oil and gas properties and assets from multiple sellers (including Vortus Investments, Alchemist, Pivotal, East Dennis, Harvard, and FBF) for approximately $83 million in total consideration, consisting of approximately $52.5 million in cash and 1,962,240 shares of Class A common stock. The company characterized this as its second acquisition as a public company and the first use of its ABS Warehouse Facility.
View raw filing on EDGAR →Presidio drew $55 million under its ABS Warehouse Facility led by Goldman Sachs with Citizens Bank participating at 40%, representing the company's first draw under this new debt financing arrangement that funded the Canyon Creek acquisition.
View raw filing on EDGAR →Presidio issued 1,962,240 shares of Class A common stock to the sellers as consideration for the Canyon Creek acquisition, undertaken in reliance on Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →Rafael Holdings furnished an investor presentation under Item 7.01 (Regulation FD Disclosure) disclosing material clinical trial progress on its lead program Trappsol® Cyclo. The presentation details completion of the Phase 3 trial's last patient last visit (LPLV) in June 2026, completion of a pre-NDA meeting, and expected NDA submission and topline data in 2H 2026. This represents a significant operational and clinical milestone for a late-stage biotechnology company, affecting investor assessment of the registrant's path to potential regulatory approval and commercialization of its lead orphan drug candidate.
View raw filing on EDGAR →Cantor Equity Partners II, Inc. completed a business combination merger with CEPT Merger Sub, resulting in a change of control. The merger subsidiary became a wholly-owned subsidiary of Pubco (PINECREST MERGER SUB), and 6,842,508 shares were redeemed in connection with the transaction.
View raw filing on EDGAR →CEPT notified NASDAQ on July 1, 2026 requesting suspension of trading of its Class A ordinary shares effective July 2, 2026, and filed a Form 25 to delist the shares under Section 12(b) of the Exchange Act. The company intends to file a Form 15 to deregister the shares and suspend SEC reporting obligations.
View raw filing on EDGAR →